Patents Assigned to Exelixix, Inc.
  • Method of Treating Cancer
    Publication number: 20140057943
    Abstract: This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.
    Type: Application
    Filed: September 26, 2011
    Publication date: February 27, 2014
    Applicant: Exelixix, Inc.
    Inventors: David C. Smith, Maha Hussain
  • Pyridopyrimidinone Inhibitors of Pl3Kalpha
    Publication number: 20090270430
    Abstract: The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
    Type: Application
    Filed: October 9, 2006
    Publication date: October 29, 2009
    Applicant: Exelixix, Inc.
    Inventors: Tae-Gon Baik, Chris A. Buhr, Katherine Lara, Sunghoon Ma, Morrison Mac, John M. Nuss, Longcheng Wang, Yong Wang, Bryan K.S. Yeung